Clinical conditions associated with defective polymorphonuclear leukocyte chemotaxis
- PMID: 407800
- PMCID: PMC2032383
Clinical conditions associated with defective polymorphonuclear leukocyte chemotaxis
Abstract
Impressive numbers of clinical conditions are associated with defective leukocyte chemotaxis. In many, this cellular dysfunction is associated with other abnormalities of the immune response, but in others abnormal chemotactic responsiveness of leukocytes is the only abnormality of function identified in the laboratory. Patients are usually selected for study because of unusually severe, recurrent infections or poor response to antimicrobial agents, and therefore a frequent association between abnormality of chemotaxis and infection would be expected. Many patients demonstrate abnormal chemotaxis during remissions as well as during infections, and there seems little doubt that abnormality of chemotaxis is related to susceptibility to infections. Partial classification of disorders of chemotaxis was attempted. Major abnormalities are found when there is a primary cellular disorder or cell-directed inhibitors of chemotaxis are found. Less marked abnormalities are found when chemotactic factors are deficient.
Similar articles
-
[Clinical observations of defective monocyte chemotaxis].Rinsho Ketsueki. 1985 Sep;26(9):1463-6. Rinsho Ketsueki. 1985. PMID: 4087395 Japanese. No abstract available.
-
Chemotactic function of polymorphonuclear leukocytes from patients with recurrent infections: partial correction by levamisole "in vitro".Allergol Immunopathol (Madr). 1985 Mar-Apr;13(2):127-34. Allergol Immunopathol (Madr). 1985. PMID: 4003229
-
Recurrent bacterial infections in children.N Engl J Med. 1984 May 10;310(19):1237-43. doi: 10.1056/NEJM198405103101907. N Engl J Med. 1984. PMID: 6369141 Review. No abstract available.
-
Defective granulocyte chemotaxis in the Chediak-Higashi syndrome.J Clin Invest. 1971 Dec;50(12):2645-52. doi: 10.1172/JCI106765. J Clin Invest. 1971. PMID: 4942966 Free PMC article.
-
Pathology of chemotaxis and random mobility.Semin Hematol. 1975 Jan;12(1):59-82. Semin Hematol. 1975. PMID: 1088998 Review. No abstract available.
Cited by
-
Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.J Clin Invest. 1980 Nov;66(5):884-91. doi: 10.1172/JCI109955. J Clin Invest. 1980. PMID: 7430350 Free PMC article.
-
Neutrophil function in infection-prone children.Arch Dis Child. 1980 Oct;55(10):776-81. doi: 10.1136/adc.55.10.776. Arch Dis Child. 1980. PMID: 7436443 Free PMC article.
-
Directed migration of circulating polymorphonuclear leucocytes in patients with rheumatoid arthritis: a defect in the plasma.Ann Rheum Dis. 1979 Jun;38(3):215-8. doi: 10.1136/ard.38.3.215. Ann Rheum Dis. 1979. PMID: 485575 Free PMC article.
-
Neutrophil adherence, phagocytic-nitroblue tetrazolium reduction and chemiluminescence in canine whole blood.Vet Res Commun. 1991;15(3):181-8. doi: 10.1007/BF00343223. Vet Res Commun. 1991. PMID: 1909070
-
Chemotaxis of porcine neutrophils under agarose.Can J Comp Med. 1985 Jan;49(1):43-9. Can J Comp Med. 1985. PMID: 3886107 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources